Get the Latest Information on Recent Multiple Sclerosis Conferences from MSAA

This month, the Multiple Sclerosis Association of America (MSAA) published a summary article, which highlights the important multiple sclerosis research information presented during the 2018 American Academy of Neurology (AAN) and Consortium of MS Centers (CMSC) conferences. This news item can now be accessed on MSAA’s website.

The cascade of research driving advances in multiple sclerosis continued at the same heightened pace into 2018. The results of numerous significant studies were reported at the AAN meeting, held in Los Angeles, CA in April, and at the CMSC meeting, held in Nashville, TN in May. MSAA’s summary article offers a look at some of the most popular topics and research studies presented at the conferences, including:

  • Disease-modifying therapies (DMTs) that are currently in the research pipeline
  • Long-term efficacy, safety, and comparative analyses of approved DMTs
  • Wellness strategies, rehabilitation, and reproductive health topics, including information on exercise, symptom management, pregnancy, and more
  • Hot topics in MS, including stem cells, diet, the gut microbiome, and medical marijuana

Also included in the summary are details on the safety and efficacy of the newest disease-modifying therapy for both relapsing-remitting MS (RRMS) and progressive forms of MS, as well as information on diagnostic testing and MRI outcomes for individuals with pediatric-onset MS.

Please read and share the full article on highlights from this year’s AAN & CMSC Annual meetings.

This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The MultipleSclerosis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.

Comments

Poll